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Abstract We sought to evaluate post-operative re-
turn of urinary and sexual function in men undergoing
robotic-assisted laparoscopic radical prostatectomy
(RLRP). Prospective assessment of urinary conti-
nence and sexual function was performed in patients
undergoing RLRP. Subjective assessment involved the
use of the validated RAND-36 Item Health Survey/
UCLA Prostate Cancer Index questionnaire. Ques-
tionnaires were completed pre-operatively and at 1, 3,
6 and 12 months post-operatively. Subset analyses
were performed to assess the effect of age on func-
tional outcomes. A total of 338 consecutive patients
underwent RLRP between February 2003 and August
2005. Included patients for evaluation comprised of
21, 129, and 150 patients, aged <50, 50–59, and
‡60 years old, respectively. Kaplan–Meier curve
analysis demonstrated that younger men (<60 years)
achieved subjective continence significantly earlier
than older age group (‡60 years) (P = 0.02). Conti-
nence rates, however, equalized among all age groups
at 1 year follow-up. Younger men (<50 years) also
demonstrated a quicker and greater return of sexual
function (P = 0.01), which persisted through assess-
ment at 1 year post-operatively. Our results suggest
that younger men may have an earlier return of
continence and potency when compared to men >
60 years. Despite this finding, continence outcomes
appear to be equal among age groups after 1 year of
follow-up. Moreover, men < 60 years continue to
report superior potency outcomes compared to
men > 60 years at 1 year post-operatively. Such find-
ings are valuable in counseling patients undergoing
RLRP.
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Introduction
With the widespread use of PSA screening, more men
are being diagnosed with prostate cancer (pCA) at an
earlier age. Several open retropubic (RRP) and lapa-
roscopic radical prostatectomy (LRP) series have sug-
gested that younger men have better functional
outcomes (continence and potency) after surgery
compared to older men [1–4]. Similar data have not yet
been reported for robotic-assisted laparoscopic radical
prostatectomy (RLRP), despite excellent overall
functional outcomes being reported in large series
[5–8]. Mid-term analyses of LRP and RLRP experi-
ences continue to show comparable oncologic results
to open RRP [9]. Over the last decade, much attention
has been given to health-related quality of life
(HRQOL) outcomes after radical prostatectomy. In
this study, we evaluate the influence of age on return of
continence and potency after RLRP.
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Between February 2003 and August 2005, 338 con-
secutive patients underwent RLRP for localized pCA
at our institution. Of these men, two surgeries were
aborted secondary to positive lymph nodes on frozen
section. Eight cases were electively converted to an
open technique: five due to failure to progress due to
dense adhesions and poor tissue planes, one due to
slow, persistent bleeding, one due to posterior bladder
perforation and one due to an incidental urothelial
tumor at the bladder neck. All conversions occurred
during the initial 40 cases. All patients who underwent
sural nerve grafting (28) were also excluded from
evaluation. Patients with non-nerve sparing procedure,
or those who were pre-operatively impotent, defined as
having a SHIM score < 20, were specifically excluded
from sexual function analysis. One patient who was
incontinent preoperatively was excluded from urinary
function analysis.
Surgical technique
All RLRP cases were performed by two surgeons
(A.L.S. and G.P.Z.) using the 3-arm Da Vinci Robotic
System (Intuitive Surgical, Sunnyvale, CA) using our
previously described technique [10–13]. Pelvic lym-
phadenectomy was routinely performed on men with a
PSA ‡ 10 ng/ml, a primary Gleason grade of 4, or
clinical stage ‡ T2b. All cases were approached trans-
peritoneally with initial dissection of the seminal vesi-
cles. The prostate was then exposed and dissected in an
antegrade fashion after bladder neck transection.
Nerve-sparing, when appropriate, was performed using
a clipless, interfascial technique without the use of
monopolar cautery. A running vesico-urethral anasto-
mosis (VUA) was performed [14] using LapraTy clips
to ensure water-tight closure [15].
Pathological analysis
All specimens were analyzed by the same uro-pathol-
ogy service at our institution as described previously
[16]. Positive surgical margin (PSM) was defined as
tumor present at the inked margin.
Functional outcome
Functional outcomes were assessed subjectively by
patient interview, as well as the validated RAND-36
Item Health Survey v2/UCLA Prostate Cancer Index
(SF-36 v2/UCLA PCI) questionnaire [17]. These
HRQOL questionnaires are a self-administered,
multi-item, disease-specific instrument to capture
health concerns central to the quality of life of men
treated for early stage prostate cancer [18]. Sub-
jective assessment was evaluated pre-operatively, and
at 1, 3, 6, and 12 months post-operatively. Ques-
tionnaire administration was performed during clinic
visits or via mail. Time to strict continence and po-
tency were obtained by calculating the number of
days from surgery the patient achieved urinary con-
trol and sexual function. For the purpose of outcome
assessment, strict continence was defined as zero pad
usage per day as well as those with occasional
security pad for high levels of physical activity. Strict
potency was defined as the ability to achieve pene-
tration and complete intercourse with or without the
use of oral type 5 phosphodiesterase (PDE-5) inhib-
itors. Patients without preoperative HRQOL surveys
(10) or those with incomplete follow-up surveys were
excluded from functional outcomes analysis. In
addition to overall potency and continence rates,
mean percent return of baseline (pROB) function
was calculated at each assessment time point. The
pROB was calculated as the percentage of pre-
operative urinary and sexual function score at all
time points for each patient.
Statistical analysis
Data collection and statistical analysis was performed
by a blinded third party. Continuous variables were
compared using t-test or ANOVA while categorical
variables were analyzed using the Chi-square and
Fisher’s exact test. Kaplan–Meier curves were con-
structed for various age groups to estimate the time to
recovery of continence and potency. Distribution
among age groups was compared using the log-rank
test. Finally, subset analysis of three age groups (<50,
50–59, and ‡60 years old) was performed to compare
functional outcomes and clinical/pathological data. A
P-value < 0.05 was considered statistically significant.
Results
After patient exclusion, a total of 300 consecutive
men undergoing RLRP for clinically localized pCA
were divided into three age groups (<50, 50–59, and
‡60 years old) comprised of 21, 129 and 150 patients,
respectively. Mean overall age was 59.4 years (range
42–76). Clinical and pathologic data are summarized
in Table 1. At a mean follow-up of 20.3 months,
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93.7% (231/300) had an undetectable PSA (less than
0.1 ng/ml).
Age-stratified comparison of clinical and patho-
logical data was performed. As expected, the prostate
weights in the youngest age group was significantly
smaller compared with the older patients (P < 0.01).
Biopsy Gleason scores were significantly lower in the
youngest age group (P = 0.01), while the differences
in clinical and pathologic stages, as well as the
Gleason score on final pathology were comparable
among the groups. There was a trend towards higher
PSMS in the youngest age group (34%), compared
with 24% and 17% in the 50–59 and ‡60 years groups,
respectively, although this difference did not reach
statistical significance (P = 0.10). The incidence of
select medical co-morbidities and risk factors was
assessed (diabetes, hypertension, cardiovascular dis-
eases and smoking) and was comparable among the
different age groups.
Continence outcomes
Continence outcomes of the age-stratified groups are
summarized in Table 2. Patient interview revealed that
67, 52 and 41% of men <50, 50–59, and ‡60 years old,
respectively, achieved strict continence at 3 months.
This difference was found to be statistically significant
(P = 0.04). No statistically significant difference was
seen between age groups at all other time points.
Furthermore, 12-month pad-free continence rates were
86, 85 and 82% for men aged <50, 50–59 and ‡60,
respectively. These results are comparable among all
age groups (P = 0.75).
Kaplan–Meier curve estimates demonstrated no
significant difference in continence outcomes between
the three age groups. However, comparison of men
aged <60 and ‡60 years demonstrated that younger
patients achieved continence earlier than the older
cohort (P = 0.02) (Fig. 1).
Table 1 Clinical and













Mean age (years) 46.9 (42–49) 55.3 (50–59) 64.7 (60–76) <0.001
Pre-op potency (%)
Potent (SHIM ‡ 20) 20 (95.2) 114 (88.4) 128 (78.7) 0.04
Impotent (SHIM < 20) 1 (4.8) 15 (11.6) 32 (21.3)
PSA (ng/dl) 5.2 (0.6–17) 6.1(0.9–25.4) 6.9 (1.4–32) 0.09
Biopsy Gleason score (%)
5–6 20 (95) 101 (78) 107 (71) 0.01
7 0 (0) 27 (21) 38 (25)
8–10 1 (5) 1 (1) 5 (3)
Clinical stage (%)
T1c 12 (57) 102 (79) 117 (78) 0.21
T2a 7 (33) 20 (16) 26 (17)
T2b 2 (10) 7 (5) 7 (5)
Nerve sparing (%)
Bilateral 14 (67) 87 (68) 83 (56) 0.08
Unilateral 7 (33) 30 (23) 43 (29)
None 0 (0) 11 (9) 23 (15)
Pathology Gleason score (%)
5–6 18 (86) 90 (70) 106 (71) 0.41
7 2 (10) 34 (26) 39 (26)
8–10 1 (5) 5 (4) 4 (3)








pT2 16 (76) 111 (86) 124 (83) 0.53
pT3a 5 (24) 15 (12) 20 (13)
pT3b 0 (0) 3 (2) 5 (3)
Positive margins (%)
Overall 7 (34) 31 (24) 25 (17) 0.10
pT2 4 (25) 22 (19) 11 (8.9) 0.03
pT3 3 (60) 9 (50) 14 (56) 0.89
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HRQOL questionnaire urinary function results re-
vealed 1, 3, 6 and 12 month pROB urinary function of
44.2, 65.1, 78.2 and 85.1% for men aged <50; 40.8, 62.4,
73.7 and 83.2% for men aged 50–60; 39.5, 55.2, 70.4 and
80.1%, respectively. No significant differences between
the age groups were observed at any of the follow up
time-points (Fig. 2).
Potency outcomes
The youngest men (<50 years old) had significantly
higher mean pre-operative SF-36 questionnaire sexual
function scores (P = 0.01). Similarly, with regards to
SHIM scores, 95.2, 88.4 and 78.7% of men aged <50,
50–60, >60, respectively, were potent pre-operatively
(P = 0.04). Potency outcomes of the age-stratified
groups are summarized in Table 2. Among men with
bilateral nerve preservation, younger men had a
superior potency recovery when compared to older
men, with the trend achieving statistical significance at
6 and 12 months (P = 0.05 and 0.01, respectively). The
youngest men (<50) had an earlier return to strict po-
tency (mean of 87 days), compared with the other age
groups (50–59 and ‡60 years old, mean of 109 and
105 days, respectively) (P = 0.01).
Kaplan–Meier curve analysis demonstrated a
significantly improved return to potency for men < 60
years when compared to men aged ‡ 60 (P < 0.01)
(Fig. 3). HRQOL questionnaire sexual function
results, for men with bilateral nerve preservation,
revealed 1, 3, 6 and 12 month pROB sexual function of
67.8, 71.1, 76.7 and 90.2% for men aged <50; 57.3, 66.9,
72.4 and 78% for men aged 50–60; 50.4, 54.7, 60.6 and
66.4% for men >60, respectively. Although there was a
Table 2 Clinical assessment
of continence and potency
after RLRP for clinically
localized prostate cancer
patients
a Includes only pre-operative
potent men with a SHIM
score ‡ 20
Variable Age < 50 Age 50–59 Age ‡ 60 P-value
Continence
0 Pads per day % continent
1 month 26% (5/19) 26% (30/117) 17% (22/137) 0.14
3 months 67% (12/18) 52% (63/121) 41% (57/140) 0.04
6 months 82% (14/18) 75% (91/122) 68% (87/128) 0.43
12 months 86% (18/21) 85% (95/112) 82% (106/130) 0.75
Potencya
Bilateral NS
1 month 46% (6/13) 41% (34/82) 36% (27/75) 0.68
3 months 69% (9/13) 55% (46/83) 46% (35/76) 0.22
6 months 85% (11/13) 69% (56/81) 54% (40/74) 0.05
12 months 86% (12/14) 77% (61/79) 61% (43/71) 0.01
Unilateral NS
1 month 43% (3/7) 39% (11/28) 13% (5/38) 0.03
3 months 50% (3/6) 48% (13/27) 31% (11/36) 0.31
6 months 66% (4/6) 58% (15/26) 37% (13/35) 0.17
12 months 71% (5/7) 64% (16/25) 40% (14/35) 0.10
Fig. 1 Kaplan–Meier estimates for continence recovery follow-
ing robotic-assisted laparoscopic radical prostatectomy (RLRP).
The distribution is significantly different between the two age
groups with the younger group taking shorter time to recover
(P = 0.02)
Fig. 2 Age-stratified, mean percent return of baseline (pROB)
urinary function based on RAND-36 Item Health Survey v2/
UCLA Prostate Cancer Index (SF-36/UCLA PCI) scores
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noticeable trend, pROB sexual function did not reach
statistical difference between age groups at all follow-
up intervals (Fig. 4).
Discussion
The introduction of robotic-assistance has the potential
to improve surgical outcomes and reduce the steep
learning curve associated with conventional LRP. The
three-dimensional visualization of periprostatic anat-
omy and the unique, wristed instrumentation afford
the surgeon incredible precision for meticulous tissue
dissection. Improved surgical outcomes, such as mini-
mal blood loss [19] and reduced patient morbidity [7],
have been well described with laparoscopic surgery.
Herrell and Smith [20] noted that the optimal onco-
logic, continence and potency outcomes of RRP have
reached a plateau, and RLRP may allow urologists to
further improve surgical technique and provide supe-
rior results. Many consider that robotic-assistance in-
creases the potential for better NVB preservation [21].
Presently, any claims of superior outcomes related to
erectile function for robotic or open prostatectomy
cannot be justified [22]. With a lack of randomized
studies and the lack of consensus regarding the optimal
instrument for assessing erectile dysfunction, such a
claim is difficult to validate.
From an oncological perspective, the finding of a
PSM after radical prostatectomy is an independent
predictor of biochemical recurrence and represents a
proxy for local disease control. Several experienced
robotic centers have reported favorable short-term
oncologic control, with PSM rates ranging from 4.5 to
16% [5–7, 11, 20, 23] for pathologically organ-con-
fined (pT2) disease. In most RLRP series, PSM rates
decrease as greater familiarity with the procedure is
obtained. Recent open series show PSM rates from
2.9 to 28% for pT2 disease [2, 3, 22, 24–26]. In our
series, we have demonstrated an overall pT2 PSM of
14.7% (37/251). There was also significant higher pT2
PSM in younger men when compared to those
>60 years old (P = 0.03). We attribute this finding to
the significant prostate size difference between the
age groups, as demonstrated in Table 1. In RRP and
LRP series, prostate size has been shown to be in-
versely related to PSMs [27–30]. Similarly, we have
also demonstrated the higher incidence of pT2-PSM
in men with smaller prostate volumes [31]. Other
than smaller prostate sizes, younger men also had a
higher degree of interfascial nerve sparing (unilateral
or bilateral) when compared to the older groups.
Interfascial nerve preservation has been associated
with higher postero-lateral PSM rates, particularly
for pT2-disease related to inadvertent capsulotomy
[11, 31].
When comparing functional outcomes among other
published series, it is important to consider other pa-
tient cohort characteristics that may influence such
results, particularly age. Patient age is a well defined,
independent risk factor of erectile dysfunction. Simi-
larly, patient age has also been associated with declines
in lean body mass and the quantitative and functional
character of skeletal muscle [32]. Equally important,
particularly for the acquirement of pelvic control for
urinary continence, is the age-related decline of neu-
ronal plasticity [33]. Aging humans show significant
impairment in acquiring new tasks; reduced neuronal
excitability in the hippocampal neurons is hypothe-
sized to play a role in this phenomenon. As such, older
men may take longer to acquire the necessary pelvic
floor reflex in order to achieve complete urinary con-
tinence.
Using a strict criterion of zero pads per day with
occasional pad use for security reasons, several
Fig. 3 Kaplan–Meier estimates for potency recovery following
RLRP. Time to potency recovery distribution is significantly
different between the two age groups (P = 0.005)
Fig. 4 Age-stratified, mean pROB sexual function for men with
bilateral nerve preservation based on SF-36/UCLA PCI scores
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academic institutions have reported continence rates
of 80–95% [5, 7, 9, 34] at 12 months after surgery.
Such results are comparable with overall subjective
continence outcomes of 84% in this series. After
stratifying results by age, younger men were noted to
achieve subjective continence earlier (67% for
men < 50 vs 41% for men > 60, at 3 months; P =
0.03). Similar finding were observed in the Kaplan–
Meier curve estimates (Fig. 1). However, at
12 months post-operatively, men of all age groups
were noted to have similar continence rates. RLRP
results in this study differ from previously published
data in open RRP series [1, 3] where better long-
term continence outcomes were observed in younger
men. Improved continence outcomes in older patients
may be attributed to better apical dissection, espe-
cially in larger prostate sizes, provided by the supe-
rior visualization and finer dissection of the surgical
planes with robot assistance. As mentioned above,
age-related decline in neuronal excitability and syn-
aptic recruitment, coupled with decreased muscle
function may help explain the early differences ob-
served between the age groups. In this series, with
increased time, older patients appear to catch up and
acquire the necessary neuro-motor function to
achieve pad-free continence.
Mean pROB urinary function was not statistically
significant between age groups for all time intervals. At
12 months post-operatively, a mean percentage of
baseline, pre-operative urinary function score (which is
not equivalent to urinary continence) of 85.1, 83.2 and
80.1% of men aged <50, 50–59 and >60 years old,
respectively, was observed. Overall pROB as a group
compared favorably to the results of other contempo-
rary radical prostatectomy series (64–74%) using sim-
ilar validated questionnaires [8, 34, 35].
Moreover, independent factors associated with
recovery of erections after surgery include younger
patient age, stronger preoperative erections, preser-
vation of NVBs, surgical technique and surgeon
experience [23, 36, 37]. Menon et al. [38] previously
presented their technique for lateral prostatic fascia
preservation during RLRP and have demonstrated
outstanding sexual function outcomes when com-
pared to other contemporary series. Their recently
published data comparing their own series of lateral
prostatic fascia sparing and conventional nerve spar-
ing RLRP resulted in significantly superior potency
outcomes in the former group (97% vs 74%,
P = 0.002) [39].
In this study, preoperative potency (defined as a
SHIM score ‡ 20) was significantly different among
the age groups (P = 0.04). When comparing different
age group functional outcomes, men below 50 years
old were noted to have an earlier return to subjective
potency, which was statistically significant at 3 and
6 months follow-up. Twelve-month potency rates for
men with bilateral nerve preservation in each age
group (<50, 50–59, and ‡60 years old) were 86, 77 and
61%, respectively (P = 0.01). These results are com-
parable to outcomes reported by expert, open sur-
geons such as Walsh [25] (91, 75 and 58%,
respectively) and Catalona [26] (90, 80 and 60%,
respectively). A trend towards better long-term
subjective results in younger men when compared
with older age groups with either bilateral or unilat-
eral nerve preservation is also demonstrated in the
Kaplan–Meier analysis (Fig. 3).
Other published data using similar validated ques-
tionnaires in assessing sexual function at 12 months
post-LRP reported inferior results (39–64%) compared
to these results of 90.2, 78 and 66.4% in the <50, 50–59,
and ‡60 year old age groups, respectively [34, 35, 40].
The pROB results showing no significant difference
between age groups at all time-points may have been
affected by our mean preoperative sexual function
scores, which showed significant differences between
age groups (P = 0.01). The higher preoperative func-
tion paralleled by higher expectations of recovery post-
operatively in younger men may explain the difficult
for these patients to achieve a greater percent of
baseline sexual function by SF-36 v2/UCLA PCI sub-
scale analysis compared to older men.
Overall long term sexual function outcome data in
younger men is similar to other published RRP data
[37]. Differences in reporting potency data, however,
has made it difficult to compare data with other pub-
lished series. Presenting both subjective clinical and
questionnaire assessment of functional outcomes has
allowed us to present a more realistic view of the actual
HRQOL outcomes of patients after RLRP.
This study has several limitations that warrant dis-
cussion. The retrospective nature of the study, based
on data from a single institution must be pointed out.
Similarly, our study is also limited by its sample size.
Questionnaire response and clinical follow-up was not
complete for all patients. Many of the patients were
from outside our geographic area and were followed
locally. Along with clinical visits, telephone interviews
and mailed HRQOL questionnaires allowed for an
85% completion rate (255/300).
RLRP experience has increased in the past few
years from 247 cases performed in 2001 [7] compared
to a predicted 35,000 cases in 2006. At the time of
writing, we have performed over 900 RLRP cases and
our surgical margin rates have dramatically improved
130 J Robotic Surg (2007) 1:125–132
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since our initial case in 2003. The frequently debated
issue regarding which surgical approach is best for the
management of clinically localized pCA [26–28] will
ultimately depend on the surgeon’s experience in car-
rying out these procedures. While we patiently await
long-term RLRP data to provide evidence for equiv-
alent cancer control to RRP data, our study reaffirms
that RLRP definitely provides favorable quality of life
outcomes for all age ranges studied.
Conclusion
Our data suggests that, as is seen using retropubic and
perineal approaches, younger men who undergo nerve-
sparing RLRP will likely have an earlier return of
continence and potency compared to older men.
However, continence outcomes appear to be equal
among age groups after 1 year of follow-up. Younger
men continue to report superior potency outcomes
compared to older men over the first postoperative
year. Such findings are valuable in counseling patients
undergoing this procedure.
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